Just three years ago, DNA testing company 23andMe was the golden child of Wall Street and Main Street. Today, the company is struggling to remain listed on the Nasdaq.
Except that leaving it somewhere is like a pseudonym. It would take a lot of effort to pinpoint to once specific person unless that person was already the sole target - then you just get a sample at their home.
No, they’ve been heading south for years. I would have loved for it to be a drop in response to the data breach, but this was just a company that was run incompetently.
Credential stuffing is a well understood part of the threat landscape that 23 and me negligently failed to account for, allowing hackers to access 7 million people's info after hacking only 14 thousand users.
If you read the article, they partner with GSK. So it's probably only going to them, not the open market. They openly say they're researching genetic meds.
Yeah it was always going to come down to this. You can't make a lot of money on a business model that involves a selling something only once per customer. Eventually they were going to have to either charge money for data storage or sell what they had.